Liver and intrahepatic bile ducts - Tumor
Reviewers: Deepali Jain, M.D. (see Reviewers page)
Revised: 9 January 2013, last major update February 2012
Copyright: (c) 2004-2013, PathologyOutlines.com, Inc.
● Very rare - <25 cases reported (Hepatol Int 2010;4:784, Surg Today 2010;40:883)
● Male predominance, age ranges from newborn to 66 years; 1-25 cm, solitary
● Liver involvement is part of multicentric process affecting other organs, particularly spleen
● May be congenital or benign slow growing tumor derived from proliferating lymph ducts, inflammatory and fibrotic processes or genetic predisposition
● May represent mesenchymal hamartoma
● Well-defined solid and cystic tumor with or without spotty calcification
Cystic and smooth mass includes gallbladder
● Cystic tumor with colloid-like content and attenuated endothelial-like cells, no atypia
Multiple cystic spaces lined by endothelium
● CD31, CD34, D2-40, LYVE-1, Prox-1
● Hemangioma: negative for lymphatic endothelial markers
End of Liver and intrahepatic bile ducts - Tumor > Benign tumors > Lymphangioma
This information is intended for physicians and related personnel, who understand that medical information is often imperfect, and must be interpreted in the context of a patient's clinical data using reasonable medical judgment. This website should not be used as a substitute for the advice of a licensed physician.
All information on this website is protected by copyright of PathologyOutlines.com, Inc. Information from third parties may also be protected by copyright. Please contact us at copyrightPathOut@gmail.com with any questions (click here for other contact information).